News About: Pharm. Industry
GSK to launch three-year training program for domestic wholesalers
GlaxoSmithKline Korea said that it will actively launch a three-year training program for domestic wholesalers in the presence or absence of partnership, while pushing for a plan to select its 50 cooperative wholesale...
AstraZeneca Korea seeks win-win strategy with domestic wholesalers via distribution streamline...
AstraZeneca Korea seeks win-win strategy with domestic wholesalers via distribution streamline project
AstraZeneca Korea said its "A night for AstraZeneca Korea's wholesalers" was splendidly held at Grand Intercont...
Pharmaceutical export 7% down in Aug.
The pharmaceutical export in Aug. this year was about 7% down from the same month last year according to the Korea Pharmaceutical Trade Association (KPTA), recording U$25,280 thousand of export and U$104,880 thousand ...
CIALIS sales may surpass VIAGRA soon.
The Aug. sales of Cialis, an impotence drug showed a full gallop stance in chasing after Viagra while Levitra slow in the market. If things are going this way, Cialis seems to surpass Viagra anytime soon.
Vice pres...
Strategic alliance between Hanil Pharm and BMS Korea hit snag
Hanil Pharm said on October 7 that it has discontinued the ongoing strategic negotiation with the U.S.-based BMS Korea due to some different terms and conditions existing between both parties, adding that the final de...
Domestic pharmaceutical firms' strategic alliance with multinational firms up
Under the ongoing system of separating drug dispensing from medical practice, the trend of strategic alliances between and domestic and foreign-invested pharmaceutical firms is expected to accelerate riding high, as s...
Foreign-invested pharmaceutical firms' outsourcing pattern in favor of local base wholesalers
Amid lingering dispute between Zuellig Korea and domestic wholesalers, the overall distribution-related outsourcing policies of multinational firms stationed in Korea have been rapidly changing.
Business sources sa...
Pfizer Korea takes legal suit against price cut
Reportedly, Pfizer Korea lodged its administrative suit, via Kim& Chang law and patent office on September 30, against the government's price cut of insurance-covered drugs based on the previous actually transacted mi...
Yuhan's new peptic ulcer drug soon on phase III studies.
Yuhan announced that the phase III clinical studies of YH1885 (Revanex: revaprazan) was scheduled to conduct for the duodenal ulcer in Oct. and for the GERD (gastro-esophageal reflux disease) in the end of this year o...
Pharmaceutical firms grappling with 2003 sales target
As the overall sales target rate of leading domestic pharmaceutical firms has remained at 80 to 90 percent by the third quarter of this year amid lingering business slump, more and more pharmaceutical firms are planni...
